Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
 
Register | Sign in
Home Page>Products
  Product News
25 Years of Revolutionary Microplate Reader Technology at SLAS 2015
Tuesday, November 25, 2014
BMG LABTECH will showcase what is new with microplate reader technology.

Imaging Cancer Growth
Tuesday, November 25, 2014
LaVision BioTec reports on the award-winning scientist Peter Friedl and his work imaging cancer growth.

Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.

Specialist Analytical Services for the Construction Industry
Tuesday, November 25, 2014
Warwick Analytical Service (WAS) reports on specialist analytical services it has been providing to Normet (UK) Ltd.

Verifying the Quality and Quantity of your ChIP DNA
Tuesday, November 25, 2014
Porvair Sciences has published a new guide to help laboratories choose the best way to verify the quality and quantity of their Chromatin Immunoprecipitation (ChIP) DNA.

Bigneat Announces Optiflow, a New Style of Safety Workstation
Tuesday, November 25, 2014
Recirculatory filtration fume system has consistent airflow ensuring the integrity of the ‘working safe-zone’ and providing the user with unhindered accessibility.

G:BOX Chemi XRQ Used at European University
Monday, November 24, 2014
Super sensitive binning results and large blot/gel capacity makes Syngene’s G:BOX Chemi XRQ a winner at major European University.

Ultra Low Temperature Rack for Tissue Storage Tubes
Monday, November 24, 2014
Micronic launch new new ultra-low temperature rack for tissue tube storage.

VivaFix™ Cell Viability Assays Launched
Monday, November 24, 2014
Bio-Rad introduces a simple way to assess the viability of cells for flow cytometry and cell sorting that is compatible with fixation.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 10722
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn